1
|
Pathak V, Roemhild K, Schipper S, Groß-Weege N, Nolte T, Ruetten S, Buhl EM, El Shafei A, Weiler M, Martin L, Marx G, Schulz V, Kiessling F, Lammers T, Koczera P. Theranostic Trigger-Responsive Carbon Monoxide-Generating Microbubbles. Small 2022; 18:e2200924. [PMID: 35363403 DOI: 10.1002/smll.202200924] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 03/04/2022] [Indexed: 06/14/2023]
Abstract
Carbon monoxide (CO) is a gaseous signaling molecule that modulates inflammation, cell survival, and recovery after myocardial infarction. However, handling and dosing of CO as a compressed gas are difficult. Here, light-triggerable and magnetic resonance imaging (MRI)-detectable CO release from dimanganese decacarbonyl (CORM-1) are demonstrated, and the development of CORM-1-loaded polymeric microbubbles (COMB) is described as an ultrasound (US)- and MRI-imageable drug delivery platform for triggerable and targeted CO therapy. COMB are synthesized via a straightforward one-step loading protocol, present a narrow size distribution peaking at 2 µm, and show excellent performance as a CORM-1 carrier and US contrast agent. Light irradiation of COMB induces local production and release of CO, as well as enhanced longitudinal and transversal relaxation rates, enabling MRI monitoring of CO delivery. Proof-of-concept studies for COMB-enabled light-triggered CO release show saturation of hemoglobin with CO in human blood, anti-inflammatory differentiation of macrophages, reduction of hypoxia-induced reactive oxygen species (ROS) production, and inhibition of ischemia-induced apoptosis in endothelial cells and cardiomyocytes. These findings indicate that CO-generating MB are interesting theranostic tools for attenuating hypoxia-associated and ROS-mediated cell and tissue damage in cardiovascular disease.
Collapse
Affiliation(s)
- Vertika Pathak
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Karolin Roemhild
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
- Institute of Pathology, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Sandra Schipper
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
- Department of General, Visceral and Transplantation Surgery, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Nicolas Groß-Weege
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Teresa Nolte
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Stephan Ruetten
- Electron Microscopy, Institute of Pathology, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Eva Miriam Buhl
- Electron Microscopy, Institute of Pathology, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Asmaa El Shafei
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Marek Weiler
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Lukas Martin
- Department of Intensive Care Medicine, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Gernot Marx
- Department of Intensive Care Medicine, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Volkmar Schulz
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Fabian Kiessling
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| | - Twan Lammers
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
- Department of Pharmaceutics, Utrecht University, Utrecht, 3584CG, The Netherlands
- Department of Targeted Therapeutics, University of Twente, Enschede, 7522 NB, The Netherlands
| | - Patrick Koczera
- Institute for Experimental Molecular Imaging, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
- Department of Intensive Care Medicine, Medical Faculty, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University Clinic, 52074, Aachen, Germany
| |
Collapse
|
2
|
Biancacci I, De Lorenzi F, Theek B, Bai X, May J, Consolino L, Baues M, Moeckel D, Gremse F, von Stillfried S, El Shafei A, Benderski K, Azadkhah Shalmani A, Wang A, Momoh J, Peña Q, Buhl EM, Buyel J, Hennink W, Kiessling F, Metselaar J, Shi Y, Lammers T. Monitoring EPR Effect Dynamics during Nanotaxane Treatment with Theranostic Polymeric Micelles. Adv Sci (Weinh) 2022; 9:e2103745. [PMID: 35072358 PMCID: PMC8981450 DOI: 10.1002/advs.202103745] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 01/09/2022] [Indexed: 06/14/2023]
Abstract
Cancer nanomedicines rely on the enhanced permeability and retention (EPR) effect for efficient target site accumulation. The EPR effect, however, is highly heterogeneous among different tumor types and cancer patients and its extent is expected to dynamically change during the course of nanochemotherapy. Here the authors set out to longitudinally study the dynamics of the EPR effect upon single- and double-dose nanotherapy with fluorophore-labeled and paclitaxel-loaded polymeric micelles. Using computed tomography-fluorescence molecular tomography imaging, it is shown that the extent of nanomedicine tumor accumulation is predictive for therapy outcome. It is also shown that the interindividual heterogeneity in EPR-based tumor accumulation significantly increases during treatment, especially for more efficient double-dose nanotaxane therapy. Furthermore, for double-dose micelle therapy, tumor accumulation significantly increased over time, from 7% injected dose per gram (ID g-1 ) upon the first administration to 15% ID g-1 upon the fifth administration, contributing to more efficient inhibition of tumor growth. These findings shed light on the dynamics of the EPR effect during nanomedicine treatment and they exemplify the importance of using imaging in nanomedicine treatment prediction and clinical translation.
Collapse
Affiliation(s)
- Ilaria Biancacci
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Federica De Lorenzi
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Benjamin Theek
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Xiangyang Bai
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Jan‐Niklas May
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Lorena Consolino
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Maike Baues
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Diana Moeckel
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Felix Gremse
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
- Gremse‐IT GmbHAachen52068Germany
| | - Saskia von Stillfried
- Institute of PathologyMedical FacultyRWTH Aachen University ClinicAachen52074Germany
| | - Asmaa El Shafei
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Karina Benderski
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Armin Azadkhah Shalmani
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Alec Wang
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Jeffrey Momoh
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Quim Peña
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Eva Miriam Buhl
- Electron Microscopy FacilityInstitute of PathologyRWTH University HospitalAachen52074Germany
| | - Johannes Buyel
- Fraunhofer Institute for Molecular Biology and Applied Ecology IMEAachen52074Germany
- Institute of Molecular BiotechnologyRWTH Aachen UniversityAachen52074Germany
| | - Wim Hennink
- Department of PharmaceuticsUtrecht Institute for Pharmaceutical SciencesUtrecht UniversityUtrecht3584 CGThe Netherlands
| | - Fabian Kiessling
- Institute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
- Fraunhofer Institute for Medical Image Computing MEVISBremen28359Germany
| | - Josbert Metselaar
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Yang Shi
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| | - Twan Lammers
- Department of Nanomedicine and TheranosticsInstitute for Experimental Molecular ImagingRWTH Aachen University ClinicAachen52074Germany
| |
Collapse
|